Matthew Plunkett, EVP, Corporate Development at CTI BIOPHARMA CORP (CTIC), sold 12,000 shares at $2.53 ($30K) on 2014-08-04, disclosed to the SEC on 2014-08-06.
Scheduled sale ($30k) by EVP, Corporate Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.45 | 900 | $2K | 7.4% |
| 2 | $2.45 | 1,300 | $3K | 10.7% |
| 3 | $2.46 | 2,000 | $5K | 16.5% |
| 4 | $2.46 | 1,100 | $3K | 9.1% |
| 5 | $2.47 | 800 | $2K | 6.6% |
| 6 | $2.47 | 600 |
| $1K |
| 5.0% |
| 7 | $2.48 | 200 | $496 | 1.7% |
| 8 | $2.49 | 600 | $1K | 5.0% |
| 9 | $2.49 | 400 | $996 | 3.3% |
| 10 | $2.50 | 1,000 | $3K | 8.4% |
| 11 | $2.50 | 800 | $2K | 6.7% |
| 12 | $2.51 | 1,500 | $4K | 12.7% |
| 13 | $2.51 | 100 | $251 | 0.8% |
| 14 | $2.52 | 100 | $252 | 0.8% |
| 15 | $2.52 | 300 | $756 | 2.5% |
| 16 | $2.53 | 300 | $759 | 2.6% |
| Total | $2.48 avg | 12,000 | $30K | 100% |
| Filing → |
| CTIC | SELL | 2016-01-06 | $15K | — | Filing → |
| CTIC | SELL | 2015-12-04 | $9K | — | Filing → |
| CTIC | SELL | 2015-11-06 | $14K | — | Filing → |